Uterine Sarcomas Future Challenges a Systematic Review

Authors

  • Sofoudis Chrisostomos Department of Obstetrics and Gynecology, Konstandopoulio General Hospital, Athens, Greece.  Author

DOI:

https://doi.org/10.47363/JGRRR/2022(4)150

Keywords:

Uterine Sarcomas, Chemotherapy, Radiotherapy, Hormonal Therapy

Abstract

According to current bibliography, uterine sarcomas represent a controversial entity among malignant lesions of female genital tract.

Age of the patient, histologic type, grading and staging of the lesion, obesity, smoking and lymph vascular infiltration reflect as most important predisposition factors concerning ultimate therapeutic mapping, especially in women of reproductive age.

After histologic establishment of lesion staging, multidisciplinary approach seems mandatory in order to discover postoperative pathways.

Series of chemotherapy, radiotherapy or hormonal therapy consist corner stone of postoperative treatment in cases of advanced stages with depicted metastatic lesions. 

Aim of our study reflects assiduous presentation and depiction of pathophysiologic pathways of such lesions strongly accompanied with proper therapeutic strategy.

Author Biography

  • Sofoudis Chrisostomos, Department of Obstetrics and Gynecology, Konstandopoulio General Hospital, Athens, Greece. 

    Chrisostomos Sofoudis, Department of Obstetrics and Gynecology, Konstandopoulio General Hospital, Athens, Greece. 

Downloads

Published

2022-04-30